Home
Contact Us
How to Cite
Get Newsletter
Become a Member
Login
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
Research News
Drug News
Conference News
AD Hypotheses
AlzSWAN
Current Hypotheses
Hypothesis Factory
Forums
Live Discussions
Virtual Conferences
Interviews
Enabling Technologies
Workshops
Research Tools
Compendia
AlzGene
AlzRisk
Antibodies
Biomarkers
Mutations
Pathways
Protocols
Research Models
Video Gallery
Resources
Bulletin Boards
Conference Calendar
Grants
Jobs
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Companies
Tutorial
Drugs in Clinical Trials
About Alzheimer's
FAQs
Diagnosis
Clinical Guidelines
Tests
Brain Banks
Treatment
Drugs and Therapies
Caregiving
Patient Care
Support Directory
AD Experiences
Member Directory
Researcher Profiles
Institutes and Labs
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Home
:
News
News
News with ID not available.
Print this page
Email this page
Alzforum News
Follow on Twitter
Text size
Share & Bookmark
Del.icio.us
Digg
Facebook
Google
Newsvine
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Most E-mailed
Most Commented
Last 7 Days
Last 30 Days
Common Ground: Is Aβ the Foundation for Multiple Dementias?
Off Key—Aβ Detunes the Theta Rhythms of the Hippocampus
TDP-43 and Tau Entangle Athletes’ Nerves in Rare Motor Neuron Disease
Insulin Resistance Correlates With Plaque, But Not Tangle, Pathology
A Toll on Memory: New Role for Immune-Related Receptor in Brain
Common Ground: Is Aβ the Foundation for Multiple Dementias?
Lilly Halts IDENTITY Trials as Patients Worsen on Secretase Inhibitor
Anti-Aβ Oligomer Headed for Phase 3 Clinical Trial
Getting to First BACE: BACE1 Inhibition Takes a Step Forward
Off Key—Aβ Detunes the Theta Rhythms of the Hippocampus
Lilly Halts IDENTITY Trials as Patients Worsen on Secretase Inhibitor
New Theory for Some ALS Cases—SOD1 Plugs Cell Power Plants
Anti-Aβ Oligomer Headed for Phase 3 Clinical Trial
Lilly Halts IDENTITY Trials as Patients Worsen on Secretase Inhibitor
What Do Clinicians Say? Peers Welcome Revised Criteria
Honolulu: The Missing Link? Tau Mediates Aβ Toxicity at Synapse
Noisy Response Greets Revised Diagnostic Criteria for AD
Paper Alert: Grappling Globulomers Improves Mouse Cognition
Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2010 Alzheimer Research Forum
Terms of Use
How to Cite
Privacy Policy
Disclaimer
Disclosure
Copyright